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Predictors of Failure After Placement of
Charleston Area Medical Center, Charleston, WV Objectives: With current nationwide increase in the number of patients on dialysis and with guidelines of Centers for Medicare and Medicaid Services, the use of peritoneal dialysis (PD) catheter continues to increase. This study examined long-term outcomes and factors associated in PD catheter survival in patients with renal failure.
Methods: A retrospective review of patients who had PD catheter placed for dialysis after renal failure. Electronic medical records were reviewed for demographic and clinical information of the patients. The primary end point of the study was PD catheter failure, defined as removal of a dysfunctional PD catheter owing to catheter-related complications. Catheter survival was estimated using the Kaplan-Meier method, whereas Cox proportional hazard regression was used to identify factors that are independently predict PD catheter failure.
Results: Seventy-one PD catheters were placed (69 had laparoscopic and 2 had open surgery) in 55 patients (mean, 1.3 attempts). Demographics at the time of catheter placement indicated more were male (52.1%) with a mean 6 standard deviation age of 58.4 6 14.5 years and body mass index of 28.8 6 9.8 kg/m 2 . The majority were in renal failure (n ¼ 59; 83.1%); the rest had stage 5 chronic kidney disease (n ¼ 12; 16.9%). Overall patency or the average time that patients remained on PD was 3 years (median, 32.2 months; Fig) . Diabetes was associated with a higher, but not significantly, rate of catheter related peritonitis (25.6 vs 9.4%; P ¼ .123). Forty-three patients (60.6%) had previous abdominal surgery. Overall PD catheter survival rates over 12, 24, and 36 months were (percent + standard error) 86.6% + 3.7%, 69.6% + 5.7%, and 62.7% + 6.1%, respectively with nine patients remaining on catheter beyond 5 years. Previous abdominal surgery (hazard ratio [HR] Objectives: Central vein stenosis and occlusion is the leading cause of fistula and graft failure in hemodialysis patients. The HeRO graft (Merit medical systems, Inc., South Jordan, Utah) is a new technique for vascular access in patients with limited treatment options. The graft, consisting of standard expanded polytetrafluroethilene graft combined with a ringsupported polyethylene outflow component, is placed subcutaneously in the upper arm providing a continuous blood flow from the brachial artery direct to the right atrium. The aim of study is to report the first results of a multicenter study on this device implantation in patients with end stages of kidney disease from three centers in Germany.
Methods: All patients with no further treatment options except catheter based dialysis and who got the HeRO device in three German hospitals were included in the study. All three hospitals are high-volume vascular access centers with common case load of more than 3000 case per year. Between the July 2013 and August 2017, a HeRO graft implantation was scheduled in 45 patients. In two patients, HeRO could not be placed for non-device-related reasons, and we, thus, retrieved data of the remaining 43 patients in whom the device was successfully implanted. In all cases, the device was implanted on the upper limb.
Results: Of the 43 patients enrolled in the study there were 18 men and 25 women. The mean age of patient was 64.3 6 16 years and 26 of the 43 had diabetes. In four cases, a Surfacer device was used for the implantation of the graft. A left-sided HeRO graft implantation performed in 21 cases and the right side was used in 22 cases. No intraoperative complications during the implantation were observed. The primary 1-year patency after implantation of HeRO graft was 39%, and the 1-year secondary patency was 94,1%. An infection after HeRO graft implantation Objectives: Over the past decade, the proportion of women within Graduate Medical Education (GME) has increased. We sought to evaluate the effect of establishing vascular surgery integrated residencies (VSIRs) on the proportion of women in VS training programs.
Methods: Resident data were obtained from the Accreditation Council for GME (ACGME) Data Resource Book for the academic years 2007 to 2016. Data were collected on overall ACGME residency numbers as well as on the following surgical subspecialties: vascular, general, thoracic, neurological, orthopedic, ear nose and throat, plastic, and urologic surgery. The number and proportion of women per year in VSIRs and VS fellowships were compared with those in the other surgical specialties.
Results: During the study period, the overall the number of women in ACGME-accredited residency programs increased from 41% (43,695 of 107,851) to 44% (57,130 of 129,720) of residents. Since the advent of the VSIR, the number of trainees within VS has grown by 56% from 221 to 501 trainees. The proportion of women in VS training programs has increased from 12% (27 of 221) to 33% (164 of 501) of trainees. This increase over the 9-year study period was greater than in any other surgical subspecialty and greatest within the VSIR. Compared with fellowship training programs, integrated surgical training programs within the same subspecialty had a higher proportion of women though variability between surgical subspecialties remained notable (Fig) .
Conclusions: Although lower than the proportion of women within all GME training programs, an increasing proportion of women have entered VS training during the study period. This seems to be related to the introduction of VSIRs and exceeds the proportion of women entering other surgical subspecialties. Further work to understand surgical specialty preferences and choice of careers after training is warranted. Objectives: The purpose of this study is to examine trends in application submission, rank list length and applicant quality for Vascular Surgery Integrated Residency.
Methods: The National Residency Match Program Results and Data from 2008 to 2017 for U.S. and Canadian seniors were compiled and mined for trends in application submission and the number of applicants a program needed to rank to fill all positions in a program. Applicant pool depth and applicant behavior regarding percentage of programs applied to was calculated. Cost of applications for the applicants was determined. Charting Outcome data from the National Residency Match Program was also reviewed for 2014 and 2016 for application board scores and experiences.
Results: Over the last 10 years, the number of vascular surgery integrated residency spots increased from 9 to 60 spots per year. Most programs offer one spot per year and none offer more than two spots. The average number of applications received by programs for those one or two spots increased from 17 applications in 2008 to 63.8 applications in 2017. The average rank list depth needed by programs to fill the one to two spots has not seen an associated increase over that time (range; 2.5-5.1; standard deviation, 0.73; Fig) . Although the number of applicants and residency spots increased over the 10-year period, the proportional depth of the applicant pool decreased from three U.S. and Canadian applicants for every one residency spot in 2008 to one and one-half applicants for every one residency spot in 2017. Application quantity received by programs climbed because applicants applied to a greater percentage of programs (Table) . There was a 103% increase in cost for the applicants over 5 years. Applicant quality metrics were available for 2 years (2014 through 2016). There was minimal change in applicant quality metrics as measured by Step 1 scores (237/239), Step 2 Scores (250/250) number of research experiences (3.7/4.2), or number of volunteer experiences (5.9/5.5). The average rank list depth for matched applicants remained stable (12.3/12.8).
Conclusions: The current system promotes multiple inefficiencies resulting in application glut. Over the 10-year history of the Vascular Match, more money and time is being spent on residency application submission and review without any change in outcome in terms of number needed to rank by applicants or programs to achieve a match. There is no associated improvement in the quality of the applicant suggesting each year more work is being done at a higher cost for the same result. 
